Failures in Phase III clinical trials have a major impact on escalating drug development costs. Clinical trial simulation can improve decisions made in learning Phase I and Phase II studies ... leading to better designs…
burden of treatment for survivors. We analyzed the efficiency of published early phase clinical trials over the past two decades and found a modest increase in the number of both ... phase followed by an integrated…
endpoint measures prior to the trial: a key to a successful outcome of phase I trial and progression to phase 2 stage of the study based on the example ... outcomes from the recently completed phase I trial study…
development model of biosimilars is expensive, as it is based on large, comparative phase 3 trials that in most cases do not provide meaningful information on the clinical equivalence (efficacy ... that this new…
Interval designs are a class of phase I trial designs for which the decision of dose assignment is determined by comparing the observed toxicity rate at the current dose with
Phase 2 of the ALN-GO1001 study. The Phase 2 is a randomized, placebo controlled, single-blind, multicenter trial in patients with PH1 with urinary oxalate ≥0.7 mmol
cases in Nepal. Methods: We conducted a multicenter, randomized (1:1), open labeled, phase III clinical trial among adults diagnosed with mild to moderate COVID-19 infections, as an inpatient
irreversible myelosuppression. Eight patients with advanced and sorafenib refractory HCC were enrolled on phase-I trial. They were assigned into 3 dose-escalated cohorts and were treated by repeated CART ... these, 7…
Microdosing in early-phase clinical trials offers a promising approach to drug development by administering subtherapeutic doses of a drug to human participants. This technique aims to gather critical pharmacokinetic…
risk and severity. Results: The review analysed data from 217 patients across Phase I clinical trials targeting solid tumors like colorectal cancer and glioblastoma. Of these, 75 patients (34.6%) experienced
enhance treatment response in LAPC. Methods: This is a nonrandomized, single-arm, Phase 1 study for adult patients with histologically confirmed LAPC. The treatment involves a nonconcurrent combination ... therapies for…
called “reference compounds” also change overtime. Many arguments exist against running phase three trials: these include the High cost and time burden (Large-scale phase three trials can be expensive ... will come…
used to control inflammation in HLH. This randomized, openlabel, single center phase II trial attempted to determine whether etoposide can be used to blunt the inflammatory response in severe COVID
with COVID-19 pneumonia. Methods: We conducted a double-blind, randomized, placebo controlled phase ii trial of intravenous NuSepin, which is an NLRP3 inflammasome inhibitor targeting GPCR19, in adults
Administration (FDA). Who is involved in the development of the guideline and what specific trial design recommendations they provide are unknown. A cross-sectional investigation of the FDA Guidance Documents…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.